Example 9

To evaluate whether ebselen has potential as an anti-muscle-wasting compound in human skeletal myotubes, differentiating human primary myoblasts were treated with dexamethasone in the presence and absence of ebselen. As a result, it was confirmed that treatment with dexamethasone reduced both the myotube diameter and the proportion of large diameter myotubes but cotreatment with ebselen inhibited the effect of dexamethasone (FIGS. 9A to 9C).

Free full text: Click here